CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening

Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening

The goal of this project is to develop and pilot test an innovative approach for overcoming barriers to cancer screening among women with physical disabilities (WWD) in rural Oregon. Many studies have shown that people with disabilities receive fewer indicated cancer screening services and are more likely to have poor cancer-related outcomes, such as late stage at diagnosis, compared to those without disabilities.

Study Overview

• Status: Completed
• Conditions: Cervical Cancer; Breast Cancer; Colorectal Cancer
• Intervention / Treatment: Other: Clinic Intervention; Other: Patient Intervention

• Study Type: Observational
• Enrollment (Actual): 1570

Contacts and Locations

Study Locations

• United States
  • Oregon
    • Portland, Oregon, United States, 97239
      • OHSU Knight Cancer Institute

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years to 75 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

Primary care clinics

Description

Inclusion Criteria:

• Female
• Aged 50-75 at time of screening
• No personal history of breast, cervical or colorectal cancer
• Not being up-to-date with at least one screening test for breast, cervical, and/or colorectal cancer
• Meets the study definition of disability per screening survey OR
• Be a woman who does not meet the definition of disability per screening survey, but has been matched to a participant who does (observation group).

Exclusion Criteria:

• Non female
• Personal history of breast, cervical, or colorectal cancer
• Coming into clinic for an urgent care issue

Study Plan

How is the study designed?

Number of groups / cohorts

4

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Patient and Clinic Intervention; The patient intervention consists of a single 90-minute interactive in-person session. The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.	Other: Clinic Intervention; The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.; Other: Patient Intervention; The patient intervention consists of a single 90-minute interactive in-person session.
Patient Intervention Only; The patient intervention consists of a single 90-minute interactive in-person session.	Other: Patient Intervention; The patient intervention consists of a single 90-minute interactive in-person session.
Clinic Intervention Only; The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.	Other: Clinic Intervention; The Clinic intervention consists of an educational video, an interactive meeting with clinicians and clinic staff, and a facilitated follow-up meeting with clinic staff.
Neither Clinic nor Patient Intervention; Consists of no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of participants with improved cancer screening	A 2 x 2 factorial study design will be used to explore individual and combined effects of a clinic-based intervention AND a patient-based intervention on improving breast, cervical and colorectal cancer screening among rural women with physical disabilities (WWD).	Duration of the study; Up to 1 year

Collaborators and Investigators

• Sponsor: OHSU Knight Cancer Institute
• Collaborators: National Institutes of Health (NIH)
• Investigators: Principal Investigator: David Buckley, MD, Oregon Health and Science University

Study record dates

Study Major Dates

• Study Start: August 1, 2013
• Primary Completion (Actual): April 1, 2015
• Study Completion (Actual): April 1, 2015

Study Registration Dates

• First Submitted: January 18, 2013
• First Submitted That Met QC Criteria: January 18, 2013
• First Posted (Estimate): January 23, 2013

Study Record Updates

• Last Update Posted (Estimate): May 22, 2015
• Last Update Submitted That Met QC Criteria: May 20, 2015
• Last Verified: May 1, 2015

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Digestive System Diseases; Neoplasms; Urogenital Neoplasms; Neoplasms by Site; Uterine Neoplasms; Genital Neoplasms, Female; Uterine Cervical Diseases; Uterine Diseases; Gastrointestinal Neoplasms; Digestive System Neoplasms; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Intestinal Neoplasms; Rectal Diseases; Uterine Cervical Neoplasms; Colorectal Neoplasms
• Other Study ID Numbers: IRB00009030